Anaprazole is a pharmaceutical drug used for the treatment of duodenal ulcers. It is classified as a proton pump inhibitor (PPI).[1] It was approved for use in China in 2023.[2] It is formulated as its sodium salt, anaprazole sodium, in enteric-coated tablets.[2]

References

  1. ^ Wang F, Niu X, Liu F, Ma X, Cheng F, Xu H, et al. (July 2024). "Safety, Tolerability, and Pharmacokinetics of Anaprazole, a Novel Proton Pump Inhibitor, in Healthy Chinese Subjects". Clinical Pharmacology in Drug Development. 13 (7): 782–789. doi:10.1002/cpdd.1405. PMID 38629191.
  2. ^ a b "Anaprazole Sodium Enteric-coated Tablets Approved for Marketing by China NMPA". Chinese National Medical Products Administration. 2023-06-25.
Allikas: https://en.wikipedia.org/wiki/Anaprazole
No tags for this post.